T 1229/17 (Analysis of glatiramer acetate batches/MOMENTA) of 01.12.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T122917.20211201
- Date of decision
- 1 December 2021
- Case number
- T 1229/17
- Petition for review of
- -
- Application number
- 09733444.5
- IPC class
- C07K 14/00G01N 33/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- ANALYSIS OF AMINO ACID COPOLYMER COMPOSITIONS
- Applicant name
- Momenta Pharmaceuticals, Inc.
- Opponent name
- Actavis Group ehf
Guardian IP Consulting I/S
Generics [UK] Ltd (trading as Mylan) - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 56European Patent Convention Art 84European Patent Convention R 80Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Late-filed evidence
Amendment occasioned by ground for opposition - (yes)
Claims - clarity (yes)
Amendments - allowable (yes) extension beyond the content of the patent (no)
Inventive step - (no) MR: effect not made credible within the whole scope of claim; (yes) AR1 - Catchword
- -
- Cited cases
- -
- Citing cases
- T 0309/17
Order
For these reasons it is decided that:
The appeals are dismissed.